Licensable picture: People are seen on a crowded beach in the city of Durres during a heatwave in Albania
نتایج نمایش داده شده برای: Albania City
جستجوی عبارت اصلی: Al Blina City
pubmed.ncbi.nlm.nih.gov/39651791/Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic ...
by S Gupta · 2025 · Cited by 235 — Adding blinatumomab to combination chemotherapy in patients with newly diagnosed childhood standard-risk B-cell ALL of average or higher ...
www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1...Positioning blinatumomab in the frontline of adult B-cell ...
by H Pourhassan · 2023 · Cited by 18 — Blinatumomab is a bispecific T-cell engager. City of Hope National Medical Center, Duarte, CA, Ph-negative acute lymphoblastic leukemia (ALL).
ashpublications.org/blood/article/144/Supplement 1/729/531101/TP53...TP53 Mutations Increased the Risk of CD19 Negative Relapse ...
Aban 15, 1403 AP
TP53 mutations increased the risk of CD19 negative relapse following Blinatumomab in adults with B-cell acute lymphoblastic leukemia (B-ALL).
jnccn.org/view/journals/jnccn/23/12/article-e257067.xmlImmunotherapy in B-Cell Acute Lymphoblastic Leukemia in
Azar 10, 1404 AP
Although in recent years cure rates for children with B-cell acute lymphoblastic leukemia (B-ALL) have approached 90%, outcomes are still ...
www.mdpi.com/2077-0383/14/6/2055Integrating Blinatumomab in the Frontline Treatment in B ...
by M Canichella · 2025 · Cited by 8 — This review explores the current evidence supporting the frontline use of blinatumomab in newly diagnosed adults with B-ALL, its impact on treatment paradigms,
en.wikipedia.org/wiki/El_BalyanaEl Balyana
El Balyana is a town in the Sohag Governorate of Upper Egypt. Located on the west bank of the Nile, it is situated near the ancient Egyptian city of Abydos.
www.ercongressi.it/slides-cuneo-2018/18/13-bassan.pdfBlinatumomab in ALL and beyond
Blinatumomab in ALL and beyond: groundwork and outlook. Renato Bassan. UOC Ematologia,. Ospedale dell' Angelo e Ss. Giovanni e Paolo, Mestre – Venezia,.
onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.24783Correlates of resistance and relapse during blinatumomab ...
by I Aldoss · 2017 · Cited by 183 — Abstract. We retrospectively analyzed 65 patients with refractory/relapsed (r/r) ALL who were treated with blinatumomab for predictors of ...
leukemiarf.org/news/blinatumomab-b-cell-acute-lymphoblastic-l...Blina may be effective in first-line treatment of Pediatric B-ALL
Blinatumomab, or Blina, appears to be a safe and effective first-line treatment option for young patients with B-cell acute lymphoblastic leukemia (B-ALL)
ascopubs.org/doi/abs/10.1200/JCO.23.00594Blinatumomab Conundrum in Low-Risk Relapsed B-Cell ALL
by LD Maese · 2023 · Cited by 5 — Our case of late isolated CNS B-cell ALL relapse outlines challenges for clinicians attempting to decrease toxicity and avoid HSCT.